Hologic Inc (HOLX)

51.41 -1.18  -2.24% NASDAQ Feb 24, 12:41 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/01/2020 16:30 EDT Misc Hologic Inc Second Quarter Earnings Conference Call in 2020
05/01/2020 Earnings Hologic Inc Second Quarter Earnings in 2020 Release
03/05/2020 08:00 EST Misc Hologic Inc Annual General Meeting for 2019
01/29/2020 16:30 EST Misc Hologic Inc First Quarter Earnings Conference Call for 2020
01/29/2020 Earnings Hologic Inc First Quarter Earnings in 2020 Release
11/06/2019 16:30 EST Misc Hologic Inc Fourth Quarter Earnings Conference Call for 2019
11/06/2019 Earnings Hologic Inc Fourth Quarter Earnings in 2019 Release
07/31/2019 16:30 EDT Misc Hologic Inc Third Quarter Earnings Conference Call in 2019
07/31/2019 Earnings Hologic Inc Third Quarter Earnings in 2019 Release
05/01/2019 16:30 EDT Misc Hologic Inc Second Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.hologic.com
  • Investor Relations URL: http://investors.hologic.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: May. 01, 2020
  • Last Earnings Release: Jan. 29, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (44% of sales), diagnostics (39%) surgical (14%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.

Top Fund Holders

Symbol Name Weighting
PARMX Parnassus Mid-Cap 3.56%
FSMEX Fidelity® Select Medical Tech and Devcs 3.30%
PMEGX T. Rowe Price Instl Mid-Cap Equity Gr 2.12%
RRMGX T. Rowe Price Mid-Cap Growth R 2.04%
SFYF SoFi 50 ETF 1.97%
RRMVX T. Rowe Price Mid-Cap Value R 1.96%
MEFNX MassMutual Select Mid Cap Growth R3 1.48%
IHI iShares US Medical Devices ETF 1.37%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.